Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02200757
Title Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors CytRx
Indications

lung small cell carcinoma

Therapies

Aldoxorubicin

Topotecan

Age Groups: adult
Covered Countries USA | ESP


No variant requirements are available.